Life Science company that develops in-vitro diagnostic platforms supporting personalized cancer treatment

Cellply is a biotechnology company that develops solutions for personalized cancer therapy through diagnostic platforms that define cellular response to drug-based treatments. The micro-technologies developed by Cellply allow the ex-vivo measurement of the cellular response to different possible pharmacological treatments while maintaining the characteristics of the tumor microenvironment and arriving to provide information on the response generated by each drug on each cell of the sample. The technology supports the automation of biological protocols allowing the integration of sample preparation procedures and functional response analysis.

Date of investment March, 2014

Offices Bologna, Italy

Life Science

Founding team

Massimo Bocchi
CEO & Co-Founder

Roberto Guerrieri